%0 Case Reports
%T Role of Sirolimus and Rituximab in the Treatment of Autoimmune Hepatitis.
%A Zouridis S
%A Oo YH
%A Syn WK
%J ACG Case Rep J
%V 11
%N 7
%D 2024 Jul
%M 38994192
暂无%R 10.14309/crj.0000000000001414
%X Autoimmune hepatitis (AIH) is a rare chronic liver disease affecting annually 100,000-200,000 individuals in the United States. The first-line therapy in AIH is azathioprine and corticosteroids. However, adverse events may occur, which can preclude disease remission. In these cases, mycophenolate, mercaptopurine, and tacrolimus can be used. Rituximab is offered in difficult to treat cases. Sirolimus is an alternative regimen. However, little is known about its use in AIH. This is a challenging case of "difficult to treat" AIH managed with sirolimus and rituximab, after multiple unsuccessful trials with other medications.